David Kostman - 18 Mar 2026 Form 3 Insider Report for NICE Ltd. (NICE)

Reporting relationship
Director
Issuer ticker
NICE
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 09:05:01 UTC
Prior SEC filing
10 Mar 2026
Next SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alon Levy, Attorney-in-Fact for David Kostman

Key filing fact

David Kostman filed Form 3 for NICE Ltd. (NICE) on 18 Mar 2026.

Key facts

  • This page summarizes David Kostman's Form 3 filing for NICE Ltd. (NICE).
  • 0 reported transactions and 7 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 09:05.

Change

  • Previous filing in this sequence was filed on 10 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001874180 Primary reporting owner

Kostman David

Relationship
Director
Address
221 RIVER STREET, HOBOKEN
Signature
/s/ Alon Levy, Attorney-in-Fact for David Kostman
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NICE holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,146
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NICE holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
14,920
Exercise price
$151.63
Footnotes
F2
NICE holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,423
Exercise price
$224.18
Footnotes
F2
NICE holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
8,078
Exercise price
$232.20
Footnotes
F2
NICE holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
9,048
Exercise price
$197.42
Footnotes
F2
NICE holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
7,337
Exercise price
$206.52
Footnotes
F2
NICE holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
8,920
Exercise price
$168.46
Footnotes
F2
NICE holding Derivative

Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,467
Exercise price
$144.90
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes (i) 1,744 restricted stock units ("RSUs"), which vest in accordance with the terms of the applicable awards. Each RSU represents a contingent right to receive one Ordinary Share; and (ii) 7,635 American Depositary Receipts ("ADR"), each of which represents one Ordinary Share.

Footnote F2

The stock option is fully vested and currently exercisable.

Footnote F3

The stock option is vested and exercisable with respect to 2,616 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on March 30, 2026, June 30, 2026 and September 30, 2026.

SEC remarks

Exhibit 24 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .